DUBLIN – Three different vaccine technologies are being deployed in the desperate global effort to combat the SARS-CoV-2 virus, but Rino Rappuoli, chief scientist at the GSK Vaccines arm of Glaxosmithkline plc, said he sees traditional protein-based ...
from Google Alert - health https://ift.tt/39vs0De
via IFTTT
0 comments:
Post a Comment